Younger survivors of non-Hodgkin lymphoma are five times more likely than similar-aged children who did not have the disease to have known BRCA2 mutations, researchers at St. Jude’s Children’s Research Hospital have found.
“The increased non–Hodgkin lymphoma risk observed among BRCA2 mutation carriers supports the inclusion of pediatric or adolescent non–Hodgkin lymphoma in the spectrum of cancers associated with germline BRCA2 mutations,” lead investigator